Global Drug Eluting Peripheral Stents Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Drug Eluting Peripheral Stents Industry Forecast” looks at past sales and reviews total world Drug Eluting Peripheral Stents sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Eluting Peripheral Stents sales for 2023 through 2029. With Drug Eluting Peripheral Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Peripheral Stents industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Peripheral Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Peripheral Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug Eluting Peripheral Stents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Peripheral Stents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Peripheral Stents.
The global Drug Eluting Peripheral Stents market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Eluting Peripheral Stents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Eluting Peripheral Stents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Eluting Peripheral Stents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Eluting Peripheral Stents players cover Boston Scientific Corporation, W. L. Gore & Associates, Abbott Laboratories, iVascular SLU., Meril Life Sciences Pvt. Ltd. and Stentys SA, Cook Medical Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Peripheral Stents market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Drug Eluting Peripheral Stents market?
What factors are driving Drug Eluting Peripheral Stents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Eluting Peripheral Stents market opportunities vary by end market size?
How does Drug Eluting Peripheral Stents break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Drug Eluting Peripheral Stents Industry Forecast” looks at past sales and reviews total world Drug Eluting Peripheral Stents sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Eluting Peripheral Stents sales for 2023 through 2029. With Drug Eluting Peripheral Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Peripheral Stents industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Peripheral Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Peripheral Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug Eluting Peripheral Stents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Peripheral Stents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Peripheral Stents.
The global Drug Eluting Peripheral Stents market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Eluting Peripheral Stents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Eluting Peripheral Stents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Eluting Peripheral Stents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Eluting Peripheral Stents players cover Boston Scientific Corporation, W. L. Gore & Associates, Abbott Laboratories, iVascular SLU., Meril Life Sciences Pvt. Ltd. and Stentys SA, Cook Medical Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Peripheral Stents market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Carotid Artery
- Iliac Artery
- Infrapop Artery
- Renal Artery
- Carotid Artery
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers/Outpatients
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boston Scientific Corporation
- W. L. Gore & Associates
- Abbott Laboratories
- iVascular SLU.
- Meril Life Sciences Pvt. Ltd.
- Stentys SA, Cook Medical Inc.
What is the 10-year outlook for the global Drug Eluting Peripheral Stents market?
What factors are driving Drug Eluting Peripheral Stents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Eluting Peripheral Stents market opportunities vary by end market size?
How does Drug Eluting Peripheral Stents break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Peripheral Stents Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug Eluting Peripheral Stents by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug Eluting Peripheral Stents by Country/Region, 2018, 2022 & 2029
2.2 Drug Eluting Peripheral Stents Segment by Type
2.2.1 Carotid Artery
2.2.2 Iliac Artery
2.2.3 Infrapop Artery
2.2.4 Renal Artery
2.2.5 Carotid Artery
2.3 Drug Eluting Peripheral Stents Sales by Type
2.3.1 Global Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
2.3.2 Global Drug Eluting Peripheral Stents Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug Eluting Peripheral Stents Sale Price by Type (2018-2023)
2.4 Drug Eluting Peripheral Stents Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Ambulatory Surgical Centers/Outpatients
2.5 Drug Eluting Peripheral Stents Sales by Application
2.5.1 Global Drug Eluting Peripheral Stents Sale Market Share by Application (2018-2023)
2.5.2 Global Drug Eluting Peripheral Stents Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug Eluting Peripheral Stents Sale Price by Application (2018-2023)
3 GLOBAL DRUG ELUTING PERIPHERAL STENTS BY COMPANY
3.1 Global Drug Eluting Peripheral Stents Breakdown Data by Company
3.1.1 Global Drug Eluting Peripheral Stents Annual Sales by Company (2018-2023)
3.1.2 Global Drug Eluting Peripheral Stents Sales Market Share by Company (2018-2023)
3.2 Global Drug Eluting Peripheral Stents Annual Revenue by Company (2018-2023)
3.2.1 Global Drug Eluting Peripheral Stents Revenue by Company (2018-2023)
3.2.2 Global Drug Eluting Peripheral Stents Revenue Market Share by Company (2018-2023)
3.3 Global Drug Eluting Peripheral Stents Sale Price by Company
3.4 Key Manufacturers Drug Eluting Peripheral Stents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Peripheral Stents Product Location Distribution
3.4.2 Players Drug Eluting Peripheral Stents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING PERIPHERAL STENTS BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Peripheral Stents Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug Eluting Peripheral Stents Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug Eluting Peripheral Stents Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug Eluting Peripheral Stents Market Size by Country/Region (2018-2023)
4.2.1 Global Drug Eluting Peripheral Stents Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug Eluting Peripheral Stents Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug Eluting Peripheral Stents Sales Growth
4.4 APAC Drug Eluting Peripheral Stents Sales Growth
4.5 Europe Drug Eluting Peripheral Stents Sales Growth
4.6 Middle East & Africa Drug Eluting Peripheral Stents Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Peripheral Stents Sales by Country
5.1.1 Americas Drug Eluting Peripheral Stents Sales by Country (2018-2023)
5.1.2 Americas Drug Eluting Peripheral Stents Revenue by Country (2018-2023)
5.2 Americas Drug Eluting Peripheral Stents Sales by Type
5.3 Americas Drug Eluting Peripheral Stents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Peripheral Stents Sales by Region
6.1.1 APAC Drug Eluting Peripheral Stents Sales by Region (2018-2023)
6.1.2 APAC Drug Eluting Peripheral Stents Revenue by Region (2018-2023)
6.2 APAC Drug Eluting Peripheral Stents Sales by Type
6.3 APAC Drug Eluting Peripheral Stents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Peripheral Stents by Country
7.1.1 Europe Drug Eluting Peripheral Stents Sales by Country (2018-2023)
7.1.2 Europe Drug Eluting Peripheral Stents Revenue by Country (2018-2023)
7.2 Europe Drug Eluting Peripheral Stents Sales by Type
7.3 Europe Drug Eluting Peripheral Stents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Peripheral Stents by Country
8.1.1 Middle East & Africa Drug Eluting Peripheral Stents Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug Eluting Peripheral Stents Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug Eluting Peripheral Stents Sales by Type
8.3 Middle East & Africa Drug Eluting Peripheral Stents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Peripheral Stents
10.3 Manufacturing Process Analysis of Drug Eluting Peripheral Stents
10.4 Industry Chain Structure of Drug Eluting Peripheral Stents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Peripheral Stents Distributors
11.3 Drug Eluting Peripheral Stents Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING PERIPHERAL STENTS BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Peripheral Stents Market Size Forecast by Region
12.1.1 Global Drug Eluting Peripheral Stents Forecast by Region (2024-2029)
12.1.2 Global Drug Eluting Peripheral Stents Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug Eluting Peripheral Stents Forecast by Type
12.7 Global Drug Eluting Peripheral Stents Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific Corporation
13.1.1 Boston Scientific Corporation Company Information
13.1.2 Boston Scientific Corporation Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.1.3 Boston Scientific Corporation Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boston Scientific Corporation Main Business Overview
13.1.5 Boston Scientific Corporation Latest Developments
13.2 W. L. Gore & Associates
13.2.1 W. L. Gore & Associates Company Information
13.2.2 W. L. Gore & Associates Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.2.3 W. L. Gore & Associates Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 W. L. Gore & Associates Main Business Overview
13.2.5 W. L. Gore & Associates Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.3.3 Abbott Laboratories Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 iVascular SLU.
13.4.1 iVascular SLU. Company Information
13.4.2 iVascular SLU. Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.4.3 iVascular SLU. Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 iVascular SLU. Main Business Overview
13.4.5 iVascular SLU. Latest Developments
13.5 Meril Life Sciences Pvt. Ltd.
13.5.1 Meril Life Sciences Pvt. Ltd. Company Information
13.5.2 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.5.3 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Meril Life Sciences Pvt. Ltd. Main Business Overview
13.5.5 Meril Life Sciences Pvt. Ltd. Latest Developments
13.6 Stentys SA, Cook Medical Inc.
13.6.1 Stentys SA, Cook Medical Inc. Company Information
13.6.2 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.6.3 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Stentys SA, Cook Medical Inc. Main Business Overview
13.6.5 Stentys SA, Cook Medical Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Peripheral Stents Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug Eluting Peripheral Stents by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug Eluting Peripheral Stents by Country/Region, 2018, 2022 & 2029
2.2 Drug Eluting Peripheral Stents Segment by Type
2.2.1 Carotid Artery
2.2.2 Iliac Artery
2.2.3 Infrapop Artery
2.2.4 Renal Artery
2.2.5 Carotid Artery
2.3 Drug Eluting Peripheral Stents Sales by Type
2.3.1 Global Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
2.3.2 Global Drug Eluting Peripheral Stents Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug Eluting Peripheral Stents Sale Price by Type (2018-2023)
2.4 Drug Eluting Peripheral Stents Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Ambulatory Surgical Centers/Outpatients
2.5 Drug Eluting Peripheral Stents Sales by Application
2.5.1 Global Drug Eluting Peripheral Stents Sale Market Share by Application (2018-2023)
2.5.2 Global Drug Eluting Peripheral Stents Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug Eluting Peripheral Stents Sale Price by Application (2018-2023)
3 GLOBAL DRUG ELUTING PERIPHERAL STENTS BY COMPANY
3.1 Global Drug Eluting Peripheral Stents Breakdown Data by Company
3.1.1 Global Drug Eluting Peripheral Stents Annual Sales by Company (2018-2023)
3.1.2 Global Drug Eluting Peripheral Stents Sales Market Share by Company (2018-2023)
3.2 Global Drug Eluting Peripheral Stents Annual Revenue by Company (2018-2023)
3.2.1 Global Drug Eluting Peripheral Stents Revenue by Company (2018-2023)
3.2.2 Global Drug Eluting Peripheral Stents Revenue Market Share by Company (2018-2023)
3.3 Global Drug Eluting Peripheral Stents Sale Price by Company
3.4 Key Manufacturers Drug Eluting Peripheral Stents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Peripheral Stents Product Location Distribution
3.4.2 Players Drug Eluting Peripheral Stents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING PERIPHERAL STENTS BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Peripheral Stents Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug Eluting Peripheral Stents Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug Eluting Peripheral Stents Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug Eluting Peripheral Stents Market Size by Country/Region (2018-2023)
4.2.1 Global Drug Eluting Peripheral Stents Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug Eluting Peripheral Stents Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug Eluting Peripheral Stents Sales Growth
4.4 APAC Drug Eluting Peripheral Stents Sales Growth
4.5 Europe Drug Eluting Peripheral Stents Sales Growth
4.6 Middle East & Africa Drug Eluting Peripheral Stents Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Peripheral Stents Sales by Country
5.1.1 Americas Drug Eluting Peripheral Stents Sales by Country (2018-2023)
5.1.2 Americas Drug Eluting Peripheral Stents Revenue by Country (2018-2023)
5.2 Americas Drug Eluting Peripheral Stents Sales by Type
5.3 Americas Drug Eluting Peripheral Stents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Peripheral Stents Sales by Region
6.1.1 APAC Drug Eluting Peripheral Stents Sales by Region (2018-2023)
6.1.2 APAC Drug Eluting Peripheral Stents Revenue by Region (2018-2023)
6.2 APAC Drug Eluting Peripheral Stents Sales by Type
6.3 APAC Drug Eluting Peripheral Stents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Peripheral Stents by Country
7.1.1 Europe Drug Eluting Peripheral Stents Sales by Country (2018-2023)
7.1.2 Europe Drug Eluting Peripheral Stents Revenue by Country (2018-2023)
7.2 Europe Drug Eluting Peripheral Stents Sales by Type
7.3 Europe Drug Eluting Peripheral Stents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Peripheral Stents by Country
8.1.1 Middle East & Africa Drug Eluting Peripheral Stents Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug Eluting Peripheral Stents Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug Eluting Peripheral Stents Sales by Type
8.3 Middle East & Africa Drug Eluting Peripheral Stents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Peripheral Stents
10.3 Manufacturing Process Analysis of Drug Eluting Peripheral Stents
10.4 Industry Chain Structure of Drug Eluting Peripheral Stents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Peripheral Stents Distributors
11.3 Drug Eluting Peripheral Stents Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING PERIPHERAL STENTS BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Peripheral Stents Market Size Forecast by Region
12.1.1 Global Drug Eluting Peripheral Stents Forecast by Region (2024-2029)
12.1.2 Global Drug Eluting Peripheral Stents Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug Eluting Peripheral Stents Forecast by Type
12.7 Global Drug Eluting Peripheral Stents Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific Corporation
13.1.1 Boston Scientific Corporation Company Information
13.1.2 Boston Scientific Corporation Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.1.3 Boston Scientific Corporation Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boston Scientific Corporation Main Business Overview
13.1.5 Boston Scientific Corporation Latest Developments
13.2 W. L. Gore & Associates
13.2.1 W. L. Gore & Associates Company Information
13.2.2 W. L. Gore & Associates Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.2.3 W. L. Gore & Associates Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 W. L. Gore & Associates Main Business Overview
13.2.5 W. L. Gore & Associates Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.3.3 Abbott Laboratories Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 iVascular SLU.
13.4.1 iVascular SLU. Company Information
13.4.2 iVascular SLU. Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.4.3 iVascular SLU. Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 iVascular SLU. Main Business Overview
13.4.5 iVascular SLU. Latest Developments
13.5 Meril Life Sciences Pvt. Ltd.
13.5.1 Meril Life Sciences Pvt. Ltd. Company Information
13.5.2 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.5.3 Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Meril Life Sciences Pvt. Ltd. Main Business Overview
13.5.5 Meril Life Sciences Pvt. Ltd. Latest Developments
13.6 Stentys SA, Cook Medical Inc.
13.6.1 Stentys SA, Cook Medical Inc. Company Information
13.6.2 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product Portfolios and Specifications
13.6.3 Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Stentys SA, Cook Medical Inc. Main Business Overview
13.6.5 Stentys SA, Cook Medical Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Eluting Peripheral Stents Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug Eluting Peripheral Stents Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Carotid Artery
Table 4. Major Players of Iliac Artery
Table 5. Major Players of Infrapop Artery
Table 6. Major Players of Renal Artery
Table 7. Major Players of Carotid Artery
Table 8. Global Drug Eluting Peripheral Stents Sales by Type (2018-2023) & (K Units)
Table 9. Global Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Table 10. Global Drug Eluting Peripheral Stents Revenue by Type (2018-2023) & ($ million)
Table 11. Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2018-2023)
Table 12. Global Drug Eluting Peripheral Stents Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Drug Eluting Peripheral Stents Sales by Application (2018-2023) & (K Units)
Table 14. Global Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Table 15. Global Drug Eluting Peripheral Stents Revenue by Application (2018-2023)
Table 16. Global Drug Eluting Peripheral Stents Revenue Market Share by Application (2018-2023)
Table 17. Global Drug Eluting Peripheral Stents Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Drug Eluting Peripheral Stents Sales by Company (2018-2023) & (K Units)
Table 19. Global Drug Eluting Peripheral Stents Sales Market Share by Company (2018-2023)
Table 20. Global Drug Eluting Peripheral Stents Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Drug Eluting Peripheral Stents Revenue Market Share by Company (2018-2023)
Table 22. Global Drug Eluting Peripheral Stents Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Drug Eluting Peripheral Stents Producing Area Distribution and Sales Area
Table 24. Players Drug Eluting Peripheral Stents Products Offered
Table 25. Drug Eluting Peripheral Stents Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Drug Eluting Peripheral Stents Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Drug Eluting Peripheral Stents Sales Market Share Geographic Region (2018-2023)
Table 30. Global Drug Eluting Peripheral Stents Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Drug Eluting Peripheral Stents Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Drug Eluting Peripheral Stents Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Drug Eluting Peripheral Stents Sales Market Share by Country/Region (2018-2023)
Table 34. Global Drug Eluting Peripheral Stents Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Drug Eluting Peripheral Stents Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Drug Eluting Peripheral Stents Sales by Country (2018-2023) & (K Units)
Table 37. Americas Drug Eluting Peripheral Stents Sales Market Share by Country (2018-2023)
Table 38. Americas Drug Eluting Peripheral Stents Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Drug Eluting Peripheral Stents Revenue Market Share by Country (2018-2023)
Table 40. Americas Drug Eluting Peripheral Stents Sales by Type (2018-2023) & (K Units)
Table 41. Americas Drug Eluting Peripheral Stents Sales by Application (2018-2023) & (K Units)
Table 42. APAC Drug Eluting Peripheral Stents Sales by Region (2018-2023) & (K Units)
Table 43. APAC Drug Eluting Peripheral Stents Sales Market Share by Region (2018-2023)
Table 44. APAC Drug Eluting Peripheral Stents Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Drug Eluting Peripheral Stents Revenue Market Share by Region (2018-2023)
Table 46. APAC Drug Eluting Peripheral Stents Sales by Type (2018-2023) & (K Units)
Table 47. APAC Drug Eluting Peripheral Stents Sales by Application (2018-2023) & (K Units)
Table 48. Europe Drug Eluting Peripheral Stents Sales by Country (2018-2023) & (K Units)
Table 49. Europe Drug Eluting Peripheral Stents Sales Market Share by Country (2018-2023)
Table 50. Europe Drug Eluting Peripheral Stents Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Drug Eluting Peripheral Stents Revenue Market Share by Country (2018-2023)
Table 52. Europe Drug Eluting Peripheral Stents Sales by Type (2018-2023) & (K Units)
Table 53. Europe Drug Eluting Peripheral Stents Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Drug Eluting Peripheral Stents Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Drug Eluting Peripheral Stents Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Drug Eluting Peripheral Stents Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Drug Eluting Peripheral Stents Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Drug Eluting Peripheral Stents Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Drug Eluting Peripheral Stents Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Drug Eluting Peripheral Stents
Table 61. Key Market Challenges & Risks of Drug Eluting Peripheral Stents
Table 62. Key Industry Trends of Drug Eluting Peripheral Stents
Table 63. Drug Eluting Peripheral Stents Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Drug Eluting Peripheral Stents Distributors List
Table 66. Drug Eluting Peripheral Stents Customer List
Table 67. Global Drug Eluting Peripheral Stents Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Drug Eluting Peripheral Stents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Drug Eluting Peripheral Stents Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Drug Eluting Peripheral Stents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Drug Eluting Peripheral Stents Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Drug Eluting Peripheral Stents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Drug Eluting Peripheral Stents Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Drug Eluting Peripheral Stents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Drug Eluting Peripheral Stents Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Drug Eluting Peripheral Stents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Drug Eluting Peripheral Stents Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Drug Eluting Peripheral Stents Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Drug Eluting Peripheral Stents Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Drug Eluting Peripheral Stents Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Boston Scientific Corporation Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 82. Boston Scientific Corporation Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 83. Boston Scientific Corporation Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Boston Scientific Corporation Main Business
Table 85. Boston Scientific Corporation Latest Developments
Table 86. W. L. Gore & Associates Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 87. W. L. Gore & Associates Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 88. W. L. Gore & Associates Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. W. L. Gore & Associates Main Business
Table 90. W. L. Gore & Associates Latest Developments
Table 91. Abbott Laboratories Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 92. Abbott Laboratories Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 93. Abbott Laboratories Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Abbott Laboratories Main Business
Table 95. Abbott Laboratories Latest Developments
Table 96. iVascular SLU. Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 97. iVascular SLU. Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 98. iVascular SLU. Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. iVascular SLU. Main Business
Table 100. iVascular SLU. Latest Developments
Table 101. Meril Life Sciences Pvt. Ltd. Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 102. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 103. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Meril Life Sciences Pvt. Ltd. Main Business
Table 105. Meril Life Sciences Pvt. Ltd. Latest Developments
Table 106. Stentys SA, Cook Medical Inc. Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 107. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 108. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Stentys SA, Cook Medical Inc. Main Business
Table 110. Stentys SA, Cook Medical Inc. Latest Developments
Table 1. Drug Eluting Peripheral Stents Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug Eluting Peripheral Stents Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Carotid Artery
Table 4. Major Players of Iliac Artery
Table 5. Major Players of Infrapop Artery
Table 6. Major Players of Renal Artery
Table 7. Major Players of Carotid Artery
Table 8. Global Drug Eluting Peripheral Stents Sales by Type (2018-2023) & (K Units)
Table 9. Global Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Table 10. Global Drug Eluting Peripheral Stents Revenue by Type (2018-2023) & ($ million)
Table 11. Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2018-2023)
Table 12. Global Drug Eluting Peripheral Stents Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Drug Eluting Peripheral Stents Sales by Application (2018-2023) & (K Units)
Table 14. Global Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Table 15. Global Drug Eluting Peripheral Stents Revenue by Application (2018-2023)
Table 16. Global Drug Eluting Peripheral Stents Revenue Market Share by Application (2018-2023)
Table 17. Global Drug Eluting Peripheral Stents Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Drug Eluting Peripheral Stents Sales by Company (2018-2023) & (K Units)
Table 19. Global Drug Eluting Peripheral Stents Sales Market Share by Company (2018-2023)
Table 20. Global Drug Eluting Peripheral Stents Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Drug Eluting Peripheral Stents Revenue Market Share by Company (2018-2023)
Table 22. Global Drug Eluting Peripheral Stents Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Drug Eluting Peripheral Stents Producing Area Distribution and Sales Area
Table 24. Players Drug Eluting Peripheral Stents Products Offered
Table 25. Drug Eluting Peripheral Stents Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Drug Eluting Peripheral Stents Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Drug Eluting Peripheral Stents Sales Market Share Geographic Region (2018-2023)
Table 30. Global Drug Eluting Peripheral Stents Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Drug Eluting Peripheral Stents Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Drug Eluting Peripheral Stents Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Drug Eluting Peripheral Stents Sales Market Share by Country/Region (2018-2023)
Table 34. Global Drug Eluting Peripheral Stents Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Drug Eluting Peripheral Stents Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Drug Eluting Peripheral Stents Sales by Country (2018-2023) & (K Units)
Table 37. Americas Drug Eluting Peripheral Stents Sales Market Share by Country (2018-2023)
Table 38. Americas Drug Eluting Peripheral Stents Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Drug Eluting Peripheral Stents Revenue Market Share by Country (2018-2023)
Table 40. Americas Drug Eluting Peripheral Stents Sales by Type (2018-2023) & (K Units)
Table 41. Americas Drug Eluting Peripheral Stents Sales by Application (2018-2023) & (K Units)
Table 42. APAC Drug Eluting Peripheral Stents Sales by Region (2018-2023) & (K Units)
Table 43. APAC Drug Eluting Peripheral Stents Sales Market Share by Region (2018-2023)
Table 44. APAC Drug Eluting Peripheral Stents Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Drug Eluting Peripheral Stents Revenue Market Share by Region (2018-2023)
Table 46. APAC Drug Eluting Peripheral Stents Sales by Type (2018-2023) & (K Units)
Table 47. APAC Drug Eluting Peripheral Stents Sales by Application (2018-2023) & (K Units)
Table 48. Europe Drug Eluting Peripheral Stents Sales by Country (2018-2023) & (K Units)
Table 49. Europe Drug Eluting Peripheral Stents Sales Market Share by Country (2018-2023)
Table 50. Europe Drug Eluting Peripheral Stents Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Drug Eluting Peripheral Stents Revenue Market Share by Country (2018-2023)
Table 52. Europe Drug Eluting Peripheral Stents Sales by Type (2018-2023) & (K Units)
Table 53. Europe Drug Eluting Peripheral Stents Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Drug Eluting Peripheral Stents Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Drug Eluting Peripheral Stents Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Drug Eluting Peripheral Stents Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Drug Eluting Peripheral Stents Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Drug Eluting Peripheral Stents Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Drug Eluting Peripheral Stents Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Drug Eluting Peripheral Stents
Table 61. Key Market Challenges & Risks of Drug Eluting Peripheral Stents
Table 62. Key Industry Trends of Drug Eluting Peripheral Stents
Table 63. Drug Eluting Peripheral Stents Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Drug Eluting Peripheral Stents Distributors List
Table 66. Drug Eluting Peripheral Stents Customer List
Table 67. Global Drug Eluting Peripheral Stents Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Drug Eluting Peripheral Stents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Drug Eluting Peripheral Stents Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Drug Eluting Peripheral Stents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Drug Eluting Peripheral Stents Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Drug Eluting Peripheral Stents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Drug Eluting Peripheral Stents Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Drug Eluting Peripheral Stents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Drug Eluting Peripheral Stents Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Drug Eluting Peripheral Stents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Drug Eluting Peripheral Stents Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Drug Eluting Peripheral Stents Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Drug Eluting Peripheral Stents Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Drug Eluting Peripheral Stents Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Boston Scientific Corporation Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 82. Boston Scientific Corporation Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 83. Boston Scientific Corporation Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Boston Scientific Corporation Main Business
Table 85. Boston Scientific Corporation Latest Developments
Table 86. W. L. Gore & Associates Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 87. W. L. Gore & Associates Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 88. W. L. Gore & Associates Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. W. L. Gore & Associates Main Business
Table 90. W. L. Gore & Associates Latest Developments
Table 91. Abbott Laboratories Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 92. Abbott Laboratories Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 93. Abbott Laboratories Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Abbott Laboratories Main Business
Table 95. Abbott Laboratories Latest Developments
Table 96. iVascular SLU. Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 97. iVascular SLU. Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 98. iVascular SLU. Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. iVascular SLU. Main Business
Table 100. iVascular SLU. Latest Developments
Table 101. Meril Life Sciences Pvt. Ltd. Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 102. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 103. Meril Life Sciences Pvt. Ltd. Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Meril Life Sciences Pvt. Ltd. Main Business
Table 105. Meril Life Sciences Pvt. Ltd. Latest Developments
Table 106. Stentys SA, Cook Medical Inc. Basic Information, Drug Eluting Peripheral Stents Manufacturing Base, Sales Area and Its Competitors
Table 107. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Product Portfolios and Specifications
Table 108. Stentys SA, Cook Medical Inc. Drug Eluting Peripheral Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Stentys SA, Cook Medical Inc. Main Business
Table 110. Stentys SA, Cook Medical Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug Eluting Peripheral Stents
Figure 2. Drug Eluting Peripheral Stents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Peripheral Stents Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drug Eluting Peripheral Stents Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug Eluting Peripheral Stents Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Carotid Artery
Figure 10. Product Picture of Iliac Artery
Figure 11. Product Picture of Infrapop Artery
Figure 12. Product Picture of Renal Artery
Figure 13. Product Picture of Carotid Artery
Figure 14. Global Drug Eluting Peripheral Stents Sales Market Share by Type in 2022
Figure 15. Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2018-2023)
Figure 16. Drug Eluting Peripheral Stents Consumed in Hospitals
Figure 17. Global Drug Eluting Peripheral Stents Market: Hospitals (2018-2023) & (K Units)
Figure 18. Drug Eluting Peripheral Stents Consumed in Specialty Clinics
Figure 19. Global Drug Eluting Peripheral Stents Market: Specialty Clinics (2018-2023) & (K Units)
Figure 20. Drug Eluting Peripheral Stents Consumed in Ambulatory Surgical Centers/Outpatients
Figure 21. Global Drug Eluting Peripheral Stents Market: Ambulatory Surgical Centers/Outpatients (2018-2023) & (K Units)
Figure 22. Global Drug Eluting Peripheral Stents Sales Market Share by Application (2022)
Figure 23. Global Drug Eluting Peripheral Stents Revenue Market Share by Application in 2022
Figure 24. Drug Eluting Peripheral Stents Sales Market by Company in 2022 (K Units)
Figure 25. Global Drug Eluting Peripheral Stents Sales Market Share by Company in 2022
Figure 26. Drug Eluting Peripheral Stents Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Drug Eluting Peripheral Stents Revenue Market Share by Company in 2022
Figure 28. Global Drug Eluting Peripheral Stents Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Drug Eluting Peripheral Stents Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Drug Eluting Peripheral Stents Sales 2018-2023 (K Units)
Figure 31. Americas Drug Eluting Peripheral Stents Revenue 2018-2023 ($ Millions)
Figure 32. APAC Drug Eluting Peripheral Stents Sales 2018-2023 (K Units)
Figure 33. APAC Drug Eluting Peripheral Stents Revenue 2018-2023 ($ Millions)
Figure 34. Europe Drug Eluting Peripheral Stents Sales 2018-2023 (K Units)
Figure 35. Europe Drug Eluting Peripheral Stents Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Drug Eluting Peripheral Stents Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Drug Eluting Peripheral Stents Revenue 2018-2023 ($ Millions)
Figure 38. Americas Drug Eluting Peripheral Stents Sales Market Share by Country in 2022
Figure 39. Americas Drug Eluting Peripheral Stents Revenue Market Share by Country in 2022
Figure 40. Americas Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Figure 41. Americas Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Figure 42. United States Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Drug Eluting Peripheral Stents Sales Market Share by Region in 2022
Figure 47. APAC Drug Eluting Peripheral Stents Revenue Market Share by Regions in 2022
Figure 48. APAC Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Figure 49. APAC Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Figure 50. China Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Drug Eluting Peripheral Stents Sales Market Share by Country in 2022
Figure 58. Europe Drug Eluting Peripheral Stents Revenue Market Share by Country in 2022
Figure 59. Europe Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Figure 60. Europe Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Figure 61. Germany Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Drug Eluting Peripheral Stents Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Drug Eluting Peripheral Stents Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Figure 70. Egypt Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Drug Eluting Peripheral Stents in 2022
Figure 76. Manufacturing Process Analysis of Drug Eluting Peripheral Stents
Figure 77. Industry Chain Structure of Drug Eluting Peripheral Stents
Figure 78. Channels of Distribution
Figure 79. Global Drug Eluting Peripheral Stents Sales Market Forecast by Region (2024-2029)
Figure 80. Global Drug Eluting Peripheral Stents Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Drug Eluting Peripheral Stents Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Drug Eluting Peripheral Stents Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Drug Eluting Peripheral Stents Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Drug Eluting Peripheral Stents Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Drug Eluting Peripheral Stents
Figure 2. Drug Eluting Peripheral Stents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Peripheral Stents Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drug Eluting Peripheral Stents Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug Eluting Peripheral Stents Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Carotid Artery
Figure 10. Product Picture of Iliac Artery
Figure 11. Product Picture of Infrapop Artery
Figure 12. Product Picture of Renal Artery
Figure 13. Product Picture of Carotid Artery
Figure 14. Global Drug Eluting Peripheral Stents Sales Market Share by Type in 2022
Figure 15. Global Drug Eluting Peripheral Stents Revenue Market Share by Type (2018-2023)
Figure 16. Drug Eluting Peripheral Stents Consumed in Hospitals
Figure 17. Global Drug Eluting Peripheral Stents Market: Hospitals (2018-2023) & (K Units)
Figure 18. Drug Eluting Peripheral Stents Consumed in Specialty Clinics
Figure 19. Global Drug Eluting Peripheral Stents Market: Specialty Clinics (2018-2023) & (K Units)
Figure 20. Drug Eluting Peripheral Stents Consumed in Ambulatory Surgical Centers/Outpatients
Figure 21. Global Drug Eluting Peripheral Stents Market: Ambulatory Surgical Centers/Outpatients (2018-2023) & (K Units)
Figure 22. Global Drug Eluting Peripheral Stents Sales Market Share by Application (2022)
Figure 23. Global Drug Eluting Peripheral Stents Revenue Market Share by Application in 2022
Figure 24. Drug Eluting Peripheral Stents Sales Market by Company in 2022 (K Units)
Figure 25. Global Drug Eluting Peripheral Stents Sales Market Share by Company in 2022
Figure 26. Drug Eluting Peripheral Stents Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Drug Eluting Peripheral Stents Revenue Market Share by Company in 2022
Figure 28. Global Drug Eluting Peripheral Stents Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Drug Eluting Peripheral Stents Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Drug Eluting Peripheral Stents Sales 2018-2023 (K Units)
Figure 31. Americas Drug Eluting Peripheral Stents Revenue 2018-2023 ($ Millions)
Figure 32. APAC Drug Eluting Peripheral Stents Sales 2018-2023 (K Units)
Figure 33. APAC Drug Eluting Peripheral Stents Revenue 2018-2023 ($ Millions)
Figure 34. Europe Drug Eluting Peripheral Stents Sales 2018-2023 (K Units)
Figure 35. Europe Drug Eluting Peripheral Stents Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Drug Eluting Peripheral Stents Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Drug Eluting Peripheral Stents Revenue 2018-2023 ($ Millions)
Figure 38. Americas Drug Eluting Peripheral Stents Sales Market Share by Country in 2022
Figure 39. Americas Drug Eluting Peripheral Stents Revenue Market Share by Country in 2022
Figure 40. Americas Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Figure 41. Americas Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Figure 42. United States Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Drug Eluting Peripheral Stents Sales Market Share by Region in 2022
Figure 47. APAC Drug Eluting Peripheral Stents Revenue Market Share by Regions in 2022
Figure 48. APAC Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Figure 49. APAC Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Figure 50. China Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Drug Eluting Peripheral Stents Sales Market Share by Country in 2022
Figure 58. Europe Drug Eluting Peripheral Stents Revenue Market Share by Country in 2022
Figure 59. Europe Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Figure 60. Europe Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Figure 61. Germany Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Drug Eluting Peripheral Stents Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Drug Eluting Peripheral Stents Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Drug Eluting Peripheral Stents Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Drug Eluting Peripheral Stents Sales Market Share by Application (2018-2023)
Figure 70. Egypt Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Drug Eluting Peripheral Stents Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Drug Eluting Peripheral Stents in 2022
Figure 76. Manufacturing Process Analysis of Drug Eluting Peripheral Stents
Figure 77. Industry Chain Structure of Drug Eluting Peripheral Stents
Figure 78. Channels of Distribution
Figure 79. Global Drug Eluting Peripheral Stents Sales Market Forecast by Region (2024-2029)
Figure 80. Global Drug Eluting Peripheral Stents Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Drug Eluting Peripheral Stents Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Drug Eluting Peripheral Stents Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Drug Eluting Peripheral Stents Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Drug Eluting Peripheral Stents Revenue Market Share Forecast by Application (2024-2029)
